Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank69
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P69
Within normal range
vs 2Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202427.06%
2023-573.23%
202268.81%
2021-42.79%
202027.10%
2019-64.94%
2018-28.52%
2017-777.54%
2016107.53%
2015-18.24%